A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most ...
Clinical trials provide access to novel treatments, comprehensive care, and closer monitoring, improving outcomes for GI cancer patients. Multidisciplinary planning and biomarker testing are crucial ...
Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...
Hosted on MSN
The 4 Phases of Clinical Trials and How They Work
Clinical trials are studies that test new medical interventions, such as a new type of drug, surgery, or medical device, on human volunteers. They aim to determine whether the new treatment option is ...
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained. There are a number of reasons why patients with cancer are ...
Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...
Share on Pinterest Actor Rob Lowe has teamed up with Eli Lilly to encourage more people to participate in cancer clinical trials. Photography courtesy of Rob Lowe Rob Lowe shares how three generations ...
When people hear the term “clinical trial,” they often imagine someone with a serious illness, desperate for a last-resort treatment, being poked and prodded in a lab. These images are persistent, but ...
In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has created ...
Please provide your email address to receive an email when new articles are posted on . Noninferiority trials test whether a new treatment is not less efficacious than an already approved therapy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results